Associated Papers
The Role of Gene-Gene Interaction Between ADRA2A and SLC6A2 Polymorphisms in Attention System and Treatment Outcomes for Children with ADHD.
Kang J et al.
Children (basel, Switzerland), 2025
Roles of Single Nucleotide Polymorphisms in the SLC6A2 Gene in the Risk of Vasovagal Syncope Among Children in Eastern China: A Case-Control Study.
Wang M et al.
Health Science Reports, 2025
The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.
Cacabelos R et al.
Expert Opinion on Drug Metabolism & Toxicology, 2025
Pharmacogenetics of anxiety and depression in Alzheimer's disease.
Cacabelos R et al.
Pharmacogenomics, 2023
Folate Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with Alzheimer's Disease with a Change in Metabolic Profile.
Miyan J et al.
Metabolites, 2022
Candidate Genes and Pathways Associated with Gilles de la Tourette Syndrome-Where Are We?
Levy AM et al.
Genes, 2021
The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis.
Zhao X et al.
Psychiatric Genetics, 2020
Association of endothelial nitric oxide synthase (eNOS) and norepinephrine transporter (NET) genes polymorphism with type 2 diabetes mellitus.
Rizvi S et al.
Molecular Biology Reports, 2019
Genetic Variation of a DRD2 Co-expression Network is Associated with Changes in Prefrontal Function After D2 Receptors Stimulation.
Selvaggi P et al.
Cerebral Cortex (new York, N.y. : 1991), 2019
Association between T-182C, G1287A polymorphism in NET gene and suicidality in major depressive disorder in Chinese patients.
Cao SX et al.
International Journal of Psychiatry in Clinical Practice, 2018
Genetic Association of the Norepinephrine Transporter Gene G1287A Polymorphism with Risk of Schizophrenia: A Case-Control Study and Meta-Analysis.
Zhao X et al.
Genetic Testing and Molecular Biomarkers, 2018
The Relationship between the SNAP-25 Polymorphism and Omission Errors in Korean Children with Attention Deficit Hyperactivity Disorder.
Kim E et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology, 2017
Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.
Dai D et al.
Plos One, 2017
Catecholamine pathway polymorphisms and antidepressant response.
Yin L et al.
Asia-pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists, 2016
The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.
Różycka A et al.
Maturitas, 2016
Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study.
Ueda I et al.
Plos One, 2016
Association Study between Norepinephrine Transporter Gene Polymorphism and Schizophrenia in a Korean Population.
Choo M et al.
Psychiatry Investigation, 2015
Analysis of Association between Norepinephrine Transporter Gene Polymorphisms and Personality Traits of NEO-FFI in a Japanese Population.
Narita S et al.
Psychiatry Investigation, 2015
A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations.
Wang Y et al.
Medicine, 2015
[Association between GSK3β polymorphisms and the smoking habits in young Japanese].
Nagahori K et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology, 2015
TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
Yin L et al.
Pharmacopsychiatry, 2015
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Yeh YW et al.
Journal of Psychiatric Research, 2015
SERT and NET polymorphisms, temperament and antidepressant response.
Andre K et al.
Nordic Journal of Psychiatry, 2015
Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder.
Kim YK et al.
Journal of Affective Disorders, 2014
Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
Zhao X et al.
Journal of Affective Disorders, 2013
Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2013
The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population.
Li X et al.
Neural Regeneration Research, 2012
Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
Park S et al.
Behavioral and Brain Functions : Bbf, 2012
Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH et al.
Neuroscience Letters, 2012
Multiple polymorphisms in genes of the adrenergic stress system confer vulnerability to alcohol abuse.
Clarke TK et al.
Addiction Biology, 2012
The pharmacogenetics of antipsychotic treatment.
Reynolds GP
Handbook of Experimental Pharmacology, 2012
Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.
Xu Z et al.
Journal of Affective Disorders, 2011
The 1287 G/A polymorphism of the norepinephrine transporter gene (NET) is involved in commission errors in Korean children with attention deficit hyperactivity disorder.
Song DH et al.
Behavioral and Brain Functions : Bbf, 2011
Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
Lee SH et al.
Psychiatry Research, 2011
A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese.
Yeh YW et al.
Pharmacogenetics and Genomics, 2011
Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment.
Miguita K et al.
Arquivos De Neuro-psiquiatria, 2011
Pharmacogenetics of antidepressants.
Crisafulli C et al.
Frontiers in Pharmacology, 2011
Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
Kim BN et al.
Behavioral and Brain Functions : Bbf, 2010
Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.
Shiroma PR et al.
Pharmacogenomics, 2010
Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.
Zhang H et al.
Physiological Genomics, 2010
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.
Kato M et al.
Molecular Psychiatry, 2010
Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O et al.
Fundamental & Clinical Pharmacology, 2010
Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
Hahn MK et al.
Neuropharmacology, 2009
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
McGough JJ et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 2009
The role of pharmacogenetics in the treatment of depression and anxiety disorders.
Schosser A et al.
International Clinical Psychopharmacology, 2009
The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population.
Xu Y et al.
Psychiatry Research, 2009
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W et al.
Psychopharmacology, 2009
[Association of serotonin and norepinephrine transporter gene polymorphisms with the susceptibility to depression].
Min WJ et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2009
Molecular epidemiology of major depressive disorder.
Kiyohara C et al.
Environmental Health and Preventive Medicine, 2009
Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.
Higuchi H et al.
Neuropsychiatric Disease and Treatment, 2009